Hillevax Inc (HLVX) Stock

DelistedNasdaq: HLVXHilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States.

2.09
Final close · Sep 16, 2025

HLVX is no longer traded. Hillevax was delisted from the Nasdaq in September 2025.

Prices on this page are historical; the last trade was September 16, 2025 at $2.09.

Hillevax stock price history

Split-adjusted closes, 2022–2025

HLVX final trading statistics

Final close
$2.09
Final trading day
Sep 16, 2025
Market cap at delisting
$104.76M
Shares outstanding
50.13M
Final 52-week range
$1.34 – $2.17
Avg. volume (final 3 mo.)
718,730
All-time high (split-adj.)
$22.01 · Sep 2022
All-time low (split-adj.)
$1.39 · Apr 2025
Return since IPO
-89.1%
Beta
0.77
Book value / share
$2.99
Price / book
0.70
Final 52 wk
1.342.17

Hillevax earnings per share

Earnings per share

Hillevax revenue & net income

RevenueNet income

Hillevax annual financials

Hillevax Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2024$0.00-$147.3M-$3.00
FY2023$0.00-$123.6M-$3.04
FY2022$0.00-$257.0M-$13.10
FY2021$0.00-$85.0M-$9.01
FY2020$0.00-$2.1M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Hillevax Inc

HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts. As of September 17, 2025, HilleVax, Inc. operates as a subsidiary of XOMA Royalty Corporation.

Hillevax stock FAQ

What happened to Hillevax stock?

Hillevax stock was delisted from the Nasdaq. Its final close was $2.09 on September 16, 2025.

Is HLVX stock still trading?

No. HLVX was delisted from the Nasdaq in September 2025 and no longer trades on a U.S. exchange.

What was the last price of HLVX stock?

HLVX closed at $2.09 on its final trading day, September 16, 2025, for a market value of about $104.76M.

What were Hillevax's revenue and earnings in its last full fiscal year?

Hillevax reported revenue of $0.00 and net income of -$147.3M in fiscal 2024, its last full year as a public company.

When did Hillevax go public?

Hillevax Inc stock began trading on April 29, 2022.

Biotechnology stocks to research

All Healthcare stocks →